Has Lena Chang received payments from drug or device companies?

Yes. Drug and device makers reported $8,021 in general payments to Lena Chang across 170 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lena Chang did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lena Chang come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lena Chang

Adult Health · New York, NYNPI 1326298290

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Boston Scientific at 39.6% of the total. Reporting peaked in 2022 at $2,143 and has fallen 53.2% since, to $1,004 in 2025. Among adult health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,021in general payments, 2019–2025

Across 170 payments — averaging $47.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$3K
Boehringer Ingelheim$880
Novartis$661
Johnson & Johnson$643
AstraZeneca$521
Novo Nordisk$513
plus $2K from 9 others

What the payments were for

Food & beverage$8,021100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	42	$3,175
Boehringer Ingelheim	11	$880
Novartis	38	$661
Johnson & Johnson	8	$643
AstraZeneca	11	$521
Novo Nordisk	6	$513
E.r. Squibb & Sons, L.L.C.	11	$345
Pfizer	12	$301
Abbott	5	$243
Esperion Therapeutics, Inc.	6	$241
Merck	9	$171
Amgen	7	$164
Shockwave Medical, Inc	1	$98
Sanofi-aventis U.S. LLC	2	$39
GSK	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,021 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York →

Other adult health in New York

Donna CatameroNew York$279K
Alyson HartyNew York$65K
Laura GraaflandNew York$51K
Allysa SaggeseNew York$49K
Juliet EscalonNew York$46K
Teshmanie RampersaudNew York$23K
Elizabeth SavageNew York$20K
Libby LevineNew York$19K
Hyo Jin KangNew York$19K
Monica RicheyNew York$19K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →